Status:
UNKNOWN
Determination of Predictive Value of Echography Doppler Abnormalities
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Breast Cancer
Upper Extremity Deep Vein Thrombosis, Secondary
Eligibility:
FEMALE
18-80 years
Brief Summary
In order to avoid to use a traumatic and iatrogenic examen (phlebography), the purpose of the study is to validate echography doppler in the diagnosis of asymptomatic related catheter related thrombos...
Detailed Description
Phlebography is the gold standard for the diagnosis of asymptomatic catheter related thrombosis but can not be performed in about 15% of patients because of arm swelling and lack of superficial veins....
Eligibility Criteria
Inclusion
- women over 18
- histologically proven breast cancer
- localized breast cancer without metastasis
- adjuvant or neo adjuvant chemotherapy
- insertion of central catheter with port for chemotherapy
- central catheter for more than three months
- inform consent
- follow up for three months
Exclusion
- ongoing anticoagulant therapy
- previous central catheter
- femoral catheter
- double lumen catheter
- central catheter without port
- platelets \< 80G/L, TQ \< 50%, fibrinogen \< 1 g/L
- creatinin \> 175mole/L
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2012
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00714909
Start Date
November 1 2008
End Date
May 1 2012
Last Update
February 23 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saint-Louis Hospital
Paris, France, 75010